1994
DOI: 10.1016/s0021-9258(17)32515-2
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

1995
1995
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 75 publications
(19 citation statements)
references
References 28 publications
0
19
0
Order By: Relevance
“…The effects of A1AT are not obvious until both A1AT and A2M are removed. In this system, A1AT appears to play a role redundant to A2M except much weaker, due to its much slower binding to plasmin [22]. When A2M is removed from the system (Fig 5C), uPA mediated fibrinolysis becomes much more apparent.…”
Section: Upa Mediated Fibrinolysismentioning
confidence: 86%
“…The effects of A1AT are not obvious until both A1AT and A2M are removed. In this system, A1AT appears to play a role redundant to A2M except much weaker, due to its much slower binding to plasmin [22]. When A2M is removed from the system (Fig 5C), uPA mediated fibrinolysis becomes much more apparent.…”
Section: Upa Mediated Fibrinolysismentioning
confidence: 86%
“…Because plasmin is the major fibrinolytic enzyme, it is possible that reduced plasmin activity in leg ulcers could contribute to fibrosis, a very common feature of leg ulcers (Falanga, 1993). Neutrophil elastase also has fibrinolytic activity (Kolev et al, 1994), but its role in fibrinolysis during wound healing has not been established.…”
Section: Discussionmentioning
confidence: 99%
“…Plasmin (PL) was obtained by activation of plasminogen from bovine plasma (PLG, lyophilized powder, Sigma-Aldrich) by urokinase (uPA) from human urine (EMD Millipore) using 1 mg plasminogen : 35 000 U urokinase ratio based on modified literature protocols [22][23]. After activation, the nominally 1 µM concentration of the PL was exactly determined by measuring the absorbance change at 405 nm wavelength in 60 seconds of a series of Spectrozyme-PL (H-Dnorleucyl-hexahydrotyrosyl-lysine-p-nitroanilide, Sekisui Diagnostics, LLC, USA) solutions prepared in Tris (2-amino-2-(hydroxymethyl)propane-1,3-diol) buffer (20 mM Tris + 150 mM NaCl at pH = 7.4), digested by the active enzyme, as described in [24]. The active plasmin concentration was obtained as a parameter, by nonlinear fitting of the Michaelis-Menten equation to the obtained dA/dt (rate of absorbance change) vs. c S (Spectrozyme-PL concentration) data points.…”
Section: Reagents and β-Casein Layer Preparationmentioning
confidence: 99%